BriaCell Therapeutics Corp.
BCTXW · NASDAQ
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $3 |
| - Cash | $3 | $10 | $12 | $5 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$3 | -$10 | -$12 | -$2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$8 | $19 | -$6 | -$7 |
| % Margin | – | – | – | – |
| Net Income | -$8 | -$8 | -$6 | -$6 |
| % Margin | – | – | – | – |
| EPS Diluted | -4.31 | -4.26 | -1,640.18 | -0.35 |
| % Growth | -1.2% | 99.7% | -468,522.9% | – |
| Operating Cash Flow | -$8 | -$8 | -$7 | -$6 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$8 | -$8 | -$7 | -$6 |